The National Diabetic Retinopathy Laser Treatment Audit. II. Proliferative retinopathy
- PMID: 9614522
- DOI: 10.1038/eye.1998.14
The National Diabetic Retinopathy Laser Treatment Audit. II. Proliferative retinopathy
Abstract
The National Diabetic Retinopathy Laser Treatment Audit is a prospective survey of laser treatment for diabetic retinopathy throughout the United Kingdom. This paper presents data on 284 patients who were undergoing their first panretinal photocoagulation for proliferative retinopathy during a 2 month period in 1995, describing the demographic features, the level of systematic screening, the sources of referral, and the waiting times. For those cases where proliferative retinopathy was present at the first ophthalmology outpatient visit, the retinopathy was detected as a result of systematic screening in 46.8%, whilst 28.7% presented symptomatically. Of these patients 28.4% waited for more than 12 weeks from referral to the time of laser treatment, but once the patient had been listed for laser treatment this was performed within 8 weeks in 95.3%. The retinopathy features and the type of treatment given are also described. Compared with the DRS and ETDRS recommendations, at least 32.5-40.2% of eyes may be undertreated initially, and for those with high-risk characteristics these figures were at least 30.8-38.5%.
Comment in
-
The National Diabetic Retinopathy Laser Treatment Audit: implications for clinical practice in 1998.Eye (Lond). 1998;12 ( Pt 1):1. doi: 10.1038/eye.1998.1. Eye (Lond). 1998. PMID: 9614509 No abstract available.
Similar articles
-
The National Diabetic Retinopathy Laser Treatment Audit. I. Maculopathy.Eye (Lond). 1998;12 ( Pt 1):69-76. doi: 10.1038/eye.1998.13. Eye (Lond). 1998. PMID: 9614521
-
The National Diabetic Retinopathy Laser Treatment Audit. III. Clinical outcomes.Eye (Lond). 1999 Apr;13 ( Pt 2):151-9. doi: 10.1038/eye.1999.42. Eye (Lond). 1999. PMID: 10450373
-
[Results of laser photocoagulation in patients with diabetic retinopathy developed as a complication of diabetes type 2].Klin Oczna. 2006;108(1-3):66-9. Klin Oczna. 2006. PMID: 16883944 Polish.
-
[Treatment of diabetic retinopathy by photocoagulation. Indications, methods and results].Diabete Metab. 1993 Sep-Oct;19(5):414-21. Diabete Metab. 1993. PMID: 8056120 Review. French.
-
Laser treatment in diabetic retinopathy.Ophthalmologica. 2007;221(2):95-102. doi: 10.1159/000098254. Ophthalmologica. 2007. PMID: 17380063 Review.
Cited by
-
Effect of pan retinal photocoagulation on central macular thickness and visual acuity in proliferative diabetic retinopathy.Pak J Med Sci. 2016 Jan-Feb;32(1):221-4. doi: 10.12669/pjms.321.8758. Pak J Med Sci. 2016. PMID: 27022379 Free PMC article.
-
Pascal panretinal laser ablation and regression analysis in proliferative diabetic retinopathy: Manchester Pascal Study Report 4.Eye (Lond). 2011 Nov;25(11):1447-56. doi: 10.1038/eye.2011.188. Epub 2011 Aug 5. Eye (Lond). 2011. PMID: 21818132 Free PMC article. Clinical Trial.
-
World blindness: a 21st century perspective.Br J Ophthalmol. 2001 Mar;85(3):261-6. doi: 10.1136/bjo.85.3.261. Br J Ophthalmol. 2001. PMID: 11222327 Free PMC article. Review. No abstract available.
-
United Kingdom National Ophthalmology Database Study: Diabetic Retinopathy; Report 1: prevalence of centre-involving diabetic macular oedema and other grades of maculopathy and retinopathy in hospital eye services.Eye (Lond). 2013 Dec;27(12):1397-404. doi: 10.1038/eye.2013.196. Epub 2013 Sep 20. Eye (Lond). 2013. PMID: 24051410 Free PMC article.
-
Entonox as an analgesic agent during panretinal photocoagulation.Br J Ophthalmol. 2002 Oct;86(10):1107-8. doi: 10.1136/bjo.86.10.1107. Br J Ophthalmol. 2002. PMID: 12234887 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical